4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Eika S. Webb, Peng Liu, Renato Baleeiro, Nicholas R. Lemoine, Ming Yuan, Yaohe Wang. Immune checkpoint inhibitors in cancer therapy[J]. The Journal of Biomedical Research, 2018, 32(5): 317-326. DOI: 10.7555/JBR.31.20160168
Citation: Eika S. Webb, Peng Liu, Renato Baleeiro, Nicholas R. Lemoine, Ming Yuan, Yaohe Wang. Immune checkpoint inhibitors in cancer therapy[J]. The Journal of Biomedical Research, 2018, 32(5): 317-326. DOI: 10.7555/JBR.31.20160168

Immune checkpoint inhibitors in cancer therapy

Funds: 

This work was supported by The MRC DPFS grant (MR/M015696/1) and Ministry of Sciences and Technology of China (2013DFG32080).

More Information
  • Received Date: December 15, 2016
  • In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic Tlymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) which have been shown to have potent immunomodulatory effects through their function as negative regulators of T cell activation. CTLA-4, through engagement with its ligands B7-1 (CD80) and B7-2 (CD86), plays a pivotal role in attenuating the activation of na?ve and memory T cells. In contrast, PD-1 is primarily involved in modulating T cell activity in peripheral tissues via its interaction with PD-L1 and PD-L2. The discovery of these negative regulators of the immune response was crucial in the development of checkpoint inhibitors. This shifted the focus from developing therapies that targeted activation of the host immune system against cancer to checkpoint inhibitors, which aimed to mediate tumor cell destruction through the removal of coinhibitory signals blocking anti tumor T cell responses.
  • Related Articles

    [1]Chen Li, Kerui Wang, Xingfeng Mao, Xiuxiu Liu, Yingmei Lu. Upregulated inwardly rectifying K+ current-mediated hypoactivity of parvalbumin interneuron underlies autism-like deficits in Bod1-deficient mice[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240394
    [2]Yi Haowei, Talmon Geoff, Wang Jing. Glutamate in cancers: from metabolism to signaling[J]. The Journal of Biomedical Research, 2020, 34(4): 260-270. DOI: 10.7555/JBR.34.20190037
    [3]Huanqiang Wang, Congying Yang, Siyuan Wang, Tian Wang, Jingling Han, Kai Wei, Fucun Liu, Jida Xu, Xianzhen Peng, Jianming Wang. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer[J]. The Journal of Biomedical Research, 2018, 32(6): 424-433. DOI: 10.7555/JBR.32.20170065
    [4]Komal Raina, Sushil Kumar, Deepanshi Dhar, Rajesh Agarwal. Silibinin and colorectal cancer chemoprevention: a comprehensive review on mechanisms and efficacy[J]. The Journal of Biomedical Research, 2016, 30(6): 452-465. DOI: 10.7555/JBR.30.20150111
    [5]Dongsheng Gu, Kelly E Schlotman, Jingwu Xie. Deciphering the role of hedgehog signaling in pancreatic cancer[J]. The Journal of Biomedical Research, 2016, 30(5): 353-360. DOI: 10.7555/JBR.30.20150107
    [6]Jiang-Jiang Qin, Sushanta Sarkar, Sukesh Voruganti, Rajesh Agarwal, Wei Wang, Ruiwen Zhang. Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy[J]. The Journal of Biomedical Research, 2016, 30(4): 322-333. DOI: 10.7555/JBR.30.20160018
    [7]Chung S Yang, Qing Feng. Chemo/Dietary prevention of cancer: perspectives in China[J]. The Journal of Biomedical Research, 2014, 28(6): 447-455. DOI: 10.7555/JBR.28.20140079
    [8]Tinghua Hu, Yu Yao, Shuo Yu, Hui Guo, Lili Han, Wenjuan Wang, Tao Tian, Yibin Hao, Zhiyan Liu, Kejun Nan, Shuhong Wang. Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer[J]. The Journal of Biomedical Research, 2013, 27(4): 283-290. DOI: 10.7555/JBR.27.20130069
    [9]Xiaojun Chen, Jie Jiang, Hongbing Shen, Zhibin Hu. Genetic susceptibility of cervical cancer[J]. The Journal of Biomedical Research, 2011, 25(3): 155-164. DOI: 10.1016/S1674-8301(11)60020-1
    [10]Li Liu, Qi Chen, Rensheng Lai, Xiaobin Wu, Xiaoyu Wu, Fukun Liu, Guohua Xu, Yong Ji. Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer[J]. The Journal of Biomedical Research, 2010, 24(3): 187-197.
  • Cited by

    Periodical cited type(1)

    1. Hickerson BT, Khalenkov AM, Xie T, et al. Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies. Viruses, 2023, 15(8): 1698. DOI:10.3390/v15081698
    1. Hickerson BT, Khalenkov AM, Xie T, et al. Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies. Viruses, 2023, 15(8): 1698. DOI:10.3390/v15081698

    Other cited types(0)

Catalog

    Article Metrics

    Article views (5700) PDF downloads (309) Cited by(1)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return